Literature DB >> 16115099

Trials to induce protective immunity in mice and sheep by application of protoscolex and hydatid fluid antigen or whole body antigen of Echinococcus granulosus.

G R Hashemitabar1, G R Razmi, A Naghibi.   

Abstract

In the current study, soluble proteins prepared from 200 mature Echinococcus granulosus and protoscolices of sheep hydatid cysts were applied to immunize sheep and mice respectively. The samples were mechanically homogenized in a blender, sonicated and the final yield was maintained at -20 degrees C until analysis. Hydatid fluid was isolated from liver or lung of sheep under sterile conditions. In the first experiment, 15 mice were randomly allocated to three groups of five mice each. Each mouse in groups 1 and 2 was immunized with 100 microg of hydatid fluid and protoscolex proteins in 100 microl of phosphate-buffered saline (PBS) and emulsified with an equal volume of Freund's complete adjuvant (FCA) respectively. The mice of group 3 were immunized with adjuvant in PBS. The mice were boosted 4 weeks after the first vaccination with the same preparation except that FCA was replaced by Freund's incomplete adjuvant (FIA). In the second experiment, eight male or female lambs 4-6 months of age, were allocated to two groups of four lambs each. Each lamb in the test group was vaccinated subcutaneously in the neck with a 2-ml dose of vaccine (1 mg of whole body protein of E. granulosus dissolved in 1 ml of PBS plus 1 ml of FCA). Control lambs were vaccinated with adjuvant in PBS. Lambs were boosted the same way as in the first experiment. Three weeks after the second vaccination, each mouse and lamb received a challenge infection with 2000 protoscolices intraperitoneally and each lamb additionally received 10 gravid E. granulosus. All mice and sheep were killed after 7 months and examined for hydatid cysts. In these studies, protective immunity was induced in mice with protoscolex protein and with hydatid fluid, and in sheep with whole-body homogenate of E. granulosus and the levels of protection afforded were found to be 72.1, 82.6 and 90.9% respectively.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16115099     DOI: 10.1111/j.1439-0450.2005.00847.x

Source DB:  PubMed          Journal:  J Vet Med B Infect Dis Vet Public Health        ISSN: 0931-1793


  3 in total

1.  Infection and treatment immunizations for successful parasite vaccines.

Authors:  Francisca Mutapi; Peter F Billingsley; W Evan Secor
Journal:  Trends Parasitol       Date:  2013-02-15

2.  The ectodomains of the lymphocyte scavenger receptors CD5 and CD6 interact with tegumental antigens from Echinococcus granulosus sensu lato and protect mice against secondary cystic echinococcosis.

Authors:  Gustavo Mourglia-Ettlin; Sebastián Miles; María Velasco-De-Andrés; Noelia Armiger-Borràs; Marcela Cucher; Sylvia Dematteis; Francisco Lozano
Journal:  PLoS Negl Trop Dis       Date:  2018-11-30

3.  Molecular Cloning and Expression an 8-kDa Subunit of Antigen B from G1 strain of Echinococcus granulosus.

Authors:  Hakim Azizi; Bahram Kazemi; Mojgan Bandehpour; Mehdi Mohebali; Ali Khamesipour; Mojgan Aryaeipour; Mohammad Bagher Rokni
Journal:  Iran J Public Health       Date:  2015-07       Impact factor: 1.429

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.